Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

295.01
-0.9500-0.32%
Post-market: 293.20-1.8100-0.61%19:30 EDT
Volume:799.36K
Turnover:236.73M
Market Cap:14.08B
PE:-60.44
High:298.98
Open:296.97
Low:293.46
Close:295.96
52wk High:303.31
52wk Low:146.20
Shares:47.74M
Float Shares:47.20M
Volume Ratio:0.72
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.96
PE(LYR):-101.30

Loading ...

Movement Alert|Charles River Laboratories Rises 5.33% in Regular Trading, Reaffirms Full-Year Guidance at Upper End and Issues Mid-to-Long-Term Growth Targets

Market Focus
·
Sep 24

US Stocks on the MOVE-Charles River, Oracle, TD Synnex

Reuters
·
Sep 24

Charles River Rises on 2026 Forecast Update, Long-Term Targets

Reuters
·
Sep 24

Charles River Laboratories Shares Rise 5% After Co Sees FY REV Growth, Adj Profit Forecast at Upper End of Prior Guidance

THOMSON REUTERS
·
Sep 24

Charles River Laboratories Reaffirms Fiscal 2026 Guidance; Issues 2030 Growth Projections

MT Newswires Live
·
Sep 24

GUIDANCE: (CRL) Charles River Laboratories Expects 2026 Adjusted EPS at Upper End of $11.15 - $11.45, vs. FactSet Est of $11.33

MT Newswires Live
·
Sep 24

Charles River Sees 2026 Revenue, Non-GAAP EPS at Upper End of Prior Guidance Ranges

Reuters
·
Sep 24

Charles River Laboratories International, - 2030 Target for Organic Revenue Growth is 5%-7% Cagr 2027-2030

THOMSON REUTERS
·
Sep 24

Charles River Laboratories International, - Expects over $300 Mln Cumulative Savings from 2027 Through 2030

THOMSON REUTERS
·
Sep 24

Charles River Laboratories International, Inc.: Reaffirms 2026 Financial Guidance with Revenue and Non-Gaap Earnings Per Share Expected at Upper Ends of Prior Ranges

THOMSON REUTERS
·
Sep 24

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 23

Charles River Labs (CRL) Receives a New Rating from Stephens

TIPRANKS
·
Sep 22

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and AgomAb Therapeutics NV ADR (AGMB)

TIPRANKS
·
Sep 21

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 18

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and Amgen (AMGN)

TIPRANKS
·
Sep 17

Charles River price target raised to $330 from $250 at Argus

TIPRANKS
·
Sep 17

Argus Research Adjusts Charles River Laboratories International PT to $330 From $250, Maintains Buy Rating

MT Newswires Live
·
Sep 17

Charles River introduces rapid cell banking programs to reduce timelines

TIPRANKS
·
Sep 17

Charles River Launches Rapid Cell Banking Platform, Cuts Production Timeline 40% vs Industry Standard

Reuters
·
Sep 17

Charles River Laboratories International, Inc. : Argus Research Raises Target Price to $330 from $250

THOMSON REUTERS
·
Sep 17